WALTERS GROUP - 31 Dec 2025 Form 4 Insider Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Role
10%+ Owner
Signature
/s/ The Walters Group, By: /s/ Susan B. Walters, Name: Susan B. Walters, Title: General Partner
Issuer symbol
ZNTL
Transactions as of
31 Dec 2025
Net transactions value
+$7,751,968
Form type
4
Filing time
08 Jan 2026, 16:57:05 UTC
Previous filing
08 Jan 2026

Reporting Owners (3)

Name Relationship Address Signature Signature date CIK
WALTERS GROUP 10%+ Owner 8975 S. PECOS ROAD, UNIT 6A, HENDERSON /s/ The Walters Group, By: /s/ Susan B. Walters, Name: Susan B. Walters, Title: General Partner 08 Jan 2026 0001177523
WALTERS WILLIAM THURMAN 10%+ Owner 8975 S. PECOS ROAD, UNIT 6A, HENDERSON /s/ William T. Walters 08 Jan 2026 0001689655
WALTERS SUSAN BERKLEY 10%+ Owner 8975 S. PECOS ROAD, UNIT 6A, HENDERSON /s/ Susan B. Walters 08 Jan 2026 0001689761

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZNTL Common Stock Purchase $7,751,968 +6,459,973 +92% $1.20 13,509,973 31 Dec 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock reported herein (the "Shares") are held directly by The Walters Group (the "TWG"). William T. Walters may be deemed to share voting and dispositive power with respect to the Shares. Susan B. Walters is the general partner and majority member of TWG and may be deemed to share voting and dispositive power with respect to the Shares. Each Reporting Person disclaims Section 16 beneficial ownership of the Shares reported herein except to the extent of its pecuniary interest therein, if any, and the inclusion of these Shares in this report shall not be deemed an admission of beneficial ownership of any of the reported Shares for purposes of Section 16 or any other purpose.